主 講 人：Michael Bruce Nichol教授/博士
地 點(diǎn)：經(jīng)管北樓206
主 辦 方：福州大學(xué)海峽應(yīng)急管理協(xié)同創(chuàng)新中心
開(kāi)始時(shí)間：2015-11-02 16:30
結(jié)束時(shí)間：2015-11-02 18:00
lMichael B. Nichol教授/博士簡(jiǎn)介
Nichol博士期初是俄勒岡州衛(wèi)生規(guī)劃和發(fā)展署衛(wèi)生規(guī)劃師，1978-1984年成為策劃總監(jiān),，副總監(jiān),，以及西俄勒岡衛(wèi)生系統(tǒng)局的常務(wù)理事。在他擔(dān)任執(zhí)行董事期間,，該機(jī)構(gòu)開(kāi)發(fā)了第一個(gè)醫(yī)生具體收費(fèi)指南,，并公布給廣大市民。此外,，該機(jī)構(gòu)主辦的多個(gè)公共聽(tīng)證會(huì)使之成為俄勒岡州醫(yī)療補(bǔ)助計(jì)劃衛(wèi)生工作的重點(diǎn),。在負(fù)責(zé)醫(yī)藥經(jīng)濟(jì)與政策部期間,，Nichol教授設(shè)立了醫(yī)藥經(jīng)濟(jì)與政策科學(xué)碩士，這已經(jīng)成為該領(lǐng)域首屈一指的研究生學(xué)位之一,。他曾在多項(xiàng)國(guó)家理事會(huì)和委員會(huì)工作,，包括全國(guó)委員會(huì)的質(zhì)量保證心血管工作組，國(guó)家質(zhì)量論壇的國(guó)家自愿達(dá)成一致的治療藥物管理素質(zhì)教育與堅(jiān)持技術(shù)咨詢小組,，衛(wèi)生保健研究和質(zhì)量（AHRQ）醫(yī)療保健系統(tǒng)研究性學(xué)習(xí)機(jī)構(gòu),。除了任現(xiàn)職衛(wèi)生政策學(xué)教授，Nichol博士擔(dān)任USC price公共政策學(xué)院的臨時(shí)副院長(zhǎng),，負(fù)責(zé)學(xué)院事務(wù)和指導(dǎo)學(xué)校的研究生醫(yī)療項(xiàng)目,。這些項(xiàng)目包括法醫(yī)療管理碩士和醫(yī)療管理行政碩士。在過(guò)去的兩年中,， MHA和EMHA已經(jīng)被重新調(diào)整,，以期在學(xué)生的表現(xiàn)和職業(yè)素養(yǎng)方面有更突出的成果。尼科爾博士也是醫(yī)藥經(jīng)濟(jì)與政策的藥學(xué)院教授以及Leonard D. Schaeffer中心衛(wèi)生政策與經(jīng)濟(jì)學(xué)研究員,。尼科爾教授積極從事相關(guān)項(xiàng)目研究,，這些項(xiàng)目由聯(lián)邦及企業(yè)資助。在醫(yī)療主題方面他已經(jīng)出版了超過(guò)250同行評(píng)議的論文,，他在許多制藥和健康保險(xiǎn)公司以及在加州各大醫(yī)療組織中擔(dān)當(dāng)顧問(wèn),。
Dr. Nichol began his health care career as a health planner with the Oregon State Health Planning and Development Agency. He became planning director, associate director, and then executive director of the Western Oregon Health Systems Agency, between the years of 1978 and 1984. During his tenure as executive director, the Agency developed the first physician-specific fee guide, which was distributed to the general public. In addition, the Agency sponsored multiple public hearings as a part of the Oregon Health Decisions project, which resulted in a set of health priorities for the Oregon Medicaid program.While directing the Department of Pharmaceutical Economics and Policy, Professor Nichol developed the Master of Science in Pharmaceutical Economics and Policy, which has become one of the premier graduate degrees in the field. He has served on a number of national boards and committees, including the National Commission on Quality Assurance Cardiovascular Work Group, the National Quality Forum’s National Voluntary Consensus Standards for the Reporting of Therapeutic Drug Management Quality Education and Adherence Technical Advisory Panel, the Agency for Healthcare Research and Quality (AHRQ) Healthcare Systems Research Study Section, and a study section for the Patient Centered Outcomes and Research Institute (PCORI). Professor Nichol was President of the USC Faculty during the 2008-2009 academic year.In addition to his present appointment as Professor of Health Policy, Dr. Nichol serves as USC Price’s Interim Vice Dean for Faculty Affairs and directs the school’s Graduate Health Programs. These programs includes the Master in Health Administration and the Executive Master in Health Administration. In the last two years, both the MHA and the EMHA have been re-designed to create clear outcomes for student performance and career attainment. Dr. Nichol is also Professor of Pharmaceutical Economics and Policy in the School of Pharmacy, and a Research Fellow at the Leonard D. Schaeffer Center for Health Policy and Economics Professor Nichol maintains an active research program enabled by federal and corporate grants. He has published more than 250 peer-reviewed articles and abstracts on a variety of health topics. He regularly consults for pharmaceutical and health insurance companies, as well as large physician groups within California.
